Top compounds associated with response to PRDM16


Feature Type Standardized
Nominal ANOVA
mRNA TAE684 CCLE pan-cancer AAC 0.1 0.02
mRNA masitinib CTRPv2 pan-cancer AAC 0.083 0.02
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.083 0.02
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.03
mRNA AZ628 GDSC1000 pan-cancer AAC 0.11 0.03
mRNA Bosutinib GDSC1000 pan-cancer AAC -0.073 0.03
mRNA JW-74 CTRPv2 pan-cancer AAC 0.1 0.03
mRNA Mitomycin-C CTRPv2 pan-cancer AAC 0.074 0.03
mRNA ABT-263 FIMM pan-cancer AAC 0.36 0.03
mRNA CEP-701 FIMM pan-cancer AAC 0.3 0.03
Download CSV